To determine the importance of GS activity for proliferation of glutamine-deprived sarcomas, we utilized the well-characterized, irreversible GS inhibitor MSO29,30,34, which completely abolished proliferation of glutamine-deprived cells but had no effect on proliferation of the same cell lines grown in glutamine-containing media. The gene discussed is GLUL; the disease is sarcoma.